Related Concept Videos
Pulmonary Cycle: Exhalation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Breathing
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Gut Dysbiosis With Bacilli Dominance and Accumulation of Fermentation Products Precedes Late-onset Sepsis in Preterm Infants.
Related Experiment Video
Updated: Dec 25, 2025

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
[Bronchopulmonary dysplasia (BPD)].
1Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Deutschland.
Bronchopulmonary dysplasia (BPD) has evolved from an old form linked to mechanical ventilation to a new form in premature infants. New BPD survivors face long-term multisystem health challenges.
Area of Science:
- Neonatal medicine
- Pediatric pulmonology
- Developmental biology
Context:
- Bronchopulmonary dysplasia (BPD) is a chronic lung disease affecting premature infants.
- Historically, 'old' BPD resulted from mechanical ventilation and oxygen, causing lung fibrosis.
- Modern surfactant therapy has increased survival, leading to 'new' BPD, characterized by impaired alveolar and capillary development.
Purpose:
- To differentiate between the historical and current forms of BPD.
- To highlight the distinct pathological mechanisms and clinical implications of 'new' BPD.
- To underscore the long-term health consequences for survivors.
Summary:
- 'Old' BPD was a fibroproliferative lung disease in premature infants due to ventilation and oxygen.
- 'New' BPD, emerging with increased survival from surfactant therapy, involves arrested lung development and multisystem immaturity.
- Survivors of 'new' BPD may experience persistent lung, cardiovascular, growth, and neurodevelopmental issues into adulthood.
Impact:
- Understanding the evolution of BPD is crucial for developing targeted therapies.
- Recognizing the multisystem nature of 'new' BPD necessitates comprehensive long-term follow-up.
- Research into growth factors and stem cells shows promise for future BPD treatment strategies.

